Medication details
| Medication used | A | B | p Value |
|---|---|---|---|
| Aspirin LD, n (%) | 45 (100) | 155 (100) | NA |
| Aspirin OD, n (%) | 45 (100) | 155 (100) | NA |
| Clopidogrel LD, n (%) | 45 (100) | 130 (83.8) | <0.001 |
| Clopidogrel, n (%) | 45 (100) | 123 (79.3) | 0.0001 |
| Prasugrel, n (%) | 0 | 33 (21.3) | 0.0001 |
| Statin, n (%) | 45 (100) | 155 (100) | NA |
| B-blocker, n (%) | 27 (60) | 117 (75.5) | 0.042 |
| ACE-I/ARB, n (%) | 24 (53.3) | 98 (63.2) | 0.21 |
| CCB, n (%) | 10 (22.2) | 23 (14.8) | 0.24 |
| LWMH, n (%) | 43 (95.6) | 111 (71.6) | 0.0005 |
| Antianginal drug, n (%) | 15 (33.3) | 79 (50.9) | 0.037 |
| GPIIb/IIIa use, n (%) | 3 (6.7) | 67 (43.2) | <0.0001 |
Antiangina drugs include nitrates, trimetazidine and ranolazine.
ACE-I, ACE inhibitor; ARB, angiotensin receptor blockers; CCB, calcium channel blockers; GP, glycoprotein; LD, loading dose; LMWH, low molecular weight heparin; NA, not applicable; OD, once daily.